Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Folic Acid on SP Anti-malarial Action in Pregnant Women
NCT00120822Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jul 2002
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of folic acid in malaria (2 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Clearance of malaria parasitemia in parasitemic pregnant women at 14 days. Started Jul 2002; status: completed.
02
Drugs
folic acid
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00120822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00120822.